Clinical Trial Update: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating whether starting dronedarone early improves outcomes compared with usual care in people newly diagnosed with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Multaq (dronedarone)

Snippet

Sponsor: American Heart Association | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED